<h4>Background</h4>Uterine mesonephric-like adenocarcinoma (MLA) is a rare and biologically aggressive subtype of endometrial carcinoma, estrogen receptor (ER) and progesterone receptor (PR) are typically absent or exhibit very low expression in this type of cancer. This evidence concerns the gene ESR1 and cancer.